SN-38 loading capacity of hydrophobic polymer blend nanoparticles: formulation, optimization and efficacy evaluation
Autor: | Nikola Geskovski, Katerina Goracinova, Sonja Ugarkovic, Marina Chacorovska, Simona Dimchevska, Gjorgji Petruševski, Riste Popeski-Dimovski |
---|---|
Rok vydání: | 2016 |
Předmět: |
Drug
Materials science Polymers Drug Compounding media_common.quotation_subject Drug Evaluation Preclinical Pharmaceutical Science Nanoparticle SN-38 02 engineering and technology Irinotecan 010402 general chemistry 01 natural sciences law.invention chemistry.chemical_compound law Cell Line Tumor Drug Discovery Polymer chemistry Animals Humans Particle Size Rats Wistar Crystallization Cell Proliferation media_common Pharmacology chemistry.chemical_classification Organic Chemistry technology industry and agriculture Polymer 021001 nanoscience & nanotechnology Antineoplastic Agents Phytogenic Rats 0104 chemical sciences PLGA Treatment Outcome Chemical engineering chemistry Polycaprolactone Nanoparticles Camptothecin Female Polymer blend 0210 nano-technology Hydrophobic and Hydrophilic Interactions |
DOI: | 10.6084/m9.figshare.4487528 |
Popis: | One of the most important problems in nanoencapsulation of extremely hydrophobic drugs is poor drug loading due to rapid drug crystallization outside the polymer core. The effort to use nanoprecipitation, as a simple one-step procedure with good reproducibility and FDA approved polymers like Poly(lactic-co-glycolic acid) (PLGA) and Polycaprolactone (PCL), will only potentiate this issue. Considering that drug loading is one of the key defining characteristics, in this study we attempted to examine whether the nanoparticle (NP) core composed of two hydrophobic polymers will provide increased drug loading for 7-Ethyl-10-hydroxy-camptothecin (SN-38), relative to NPs prepared using individual polymers. D-optimal design was applied to optimize PLGA/PCL ratio in the polymer blend and the mode of addition of the amphiphilic copolymer Lutrol®F127 in order to maximize SN-38 loading and obtain NPs with acceptable size for passive tumor targeting. Drug/polymer and polymer/polymer interaction analysis pointed to high degree of compatibility and miscibility among both hydrophobic polymers, providing core configuration with higher drug loading capacity. Toxicity studies outlined the biocompatibility of the blank NPs. Increased in vitro efficacy of drug-loaded NPs compared to the free drug was confirmed by growth inhibition studies using SW-480 cell line. Additionally, the optimized NP formulation showed very promising blood circulation profile with elimination half-time of 7.4 h. |
Databáze: | OpenAIRE |
Externí odkaz: |